Browse by author
Lookup NU author(s): Professor Colin McGuckin, Dr Nicolas Forraz
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Never before in the history of human kind have we tried to keep a tissue preserved for the entire life of a human. This, however, is what is proposed with umbilical cord blood banking. The media often report on the latest 'Stem Cell' breakthrough in 'Regenerative Medicine'. Between human embryonic stem cells, adult stem cells and umbilical cord blood stem cells, it is hard to decipher what all these have done and will do for patients. Cord blood is collected after birth with no harm to mother or baby and contains stem cells with an incredible potential to form tissues including neural, liver and pancreatic tissues in a laboratory. In less than 20 years, cord blood has become the biggest real success story in stem cells, with nearly 10,000 patients treated, from blood and immune transplants, through to more controversial interventions, such as Type 1 diabetes. With ongoing clinical trials and research predicting new avenues, the future seems assured for this stem cell source. What does this predict, however, for cord blood banking? More importantly, what does it justify? © YOZMOT 2008.
Author(s): McGuckin CP, Forraz N
Publication type: Article
Publication status: Published
Journal: Medicine and Law
Year: 2008
Volume: 27
Issue: 1
Pages: 147-165
ISSN (print): 0723-1393
ISSN (electronic):
Publisher: Yozmot Heiliger (1989) Ltd.
